Don’t routinely use cancer-directed therapy for solid tumor patients with low performance status (3 or 4) or progressive after 2-3 therapeutic lines, but prioritize palliative care.
The anticancer treatments in general are likely to be ineffective in patients with solid tumors with the following characteristics: low performance status (3-4), no response to previous evidence-based therapies, not eligibility for a clinical trial, the absence of...
Don’t routinely prescribe serum cancer markers during the diagnostic or staging procedures in cancer care.
The serum tumor markers are often required in an appropriate way as they need a simple blood sample. Given the high cost of each prescription tests and the high number of required tests it represents a considerable employment of resources; in addition it represents a...
Don’t prescribe antibiotics to prevent infectious complications from neutropenia in cancer patients treated with standard dose chemotherapy.
The most frequent complication of chemotherapy is myelotoxicity with particular reference to the neutropenia. Neutropenia. is a serious cause of impairment of the immune system with the risk of infection, sepsis and septicemia. Normally the relevant pathogens are...
Do not forget to indicate in the patient health documentation (discharge letter or document for transfer to another healthcare facility) any positivity to alert microorganisms *
The indication of the positivity to alert microorganisms in the letter of discharge or in the transfer document to another healthcare facility represents an essential information to ensure the correct patient management both at home and in healthcare facility. The...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments